Founding Director

Zach brings a fresh, technology-driven perspective to the healthcare industry, drawing on his background as a trained electrical engineer with expertise in problem-solving, analytical thinking, and innovation. His focus on assisted living, memory care, and hospice services reflects a deep commitment to improving healthcare systems and outcomes. Leveraging engineering principles of precision, reliability, and continuous improvement, Zach is dedicated to creating supportive, efficient, and person-centered care environments. He is at the forefront of integrating disruptive technologies, including resident ambulatory drones and senior-focused computer vision, to redefine care delivery and enhance quality of life for residents. Mentored by industry leaders in mergers and acquisitions, Zach leads a team actively acquiring reputable home health companies, providing owners with seamless exit strategies while prioritizing patient care and operational excellence. Zach’s vision is to revolutionize healthcare by combining strategic growth and technological innovation to transform care delivery.

Chairman

Paul Gray is a seasoned dealmaker and accomplished entrepreneur with a distinguished career in healthcare acquisitions and management. As the former Chairman and CEO of Century Care of America, Paul spearheaded the acquisition, development, and management of 26 healthcare facilities, ultimately consolidating assets worth approximately $80 million. His leadership earned him recognition as Entrepreneur of the Year in Houston, Texas, by Merrill Lynch and Ernst & Young. A pioneer in healthcare innovation, Paul led the design, construction, financing, and management of one of the nation’s first Continuum of Care Retirement Communities (CCRC), which achieved a remarkable return on investment by selling for $16.5 million after just three years. With deep expertise in mergers and acquisitions and strategic planning, Paul has consistently delivered transformative results. His financial acumen, honed as a CPA and former KPMG partner, enables him to structure and execute complex transactions that drive growth and profitability in the healthcare sector.

Interim Chief Financial Officer

Marc is a seasoned leader and Certified Public Accountant with over 47 years of experience in international tax and mergers and acquisitions (M&A). He retired from KPMG LLP after an illustrious 41-year career, including 31 years as an International Tax Partner, where he led efforts in M&A transactions, tax compliance, and the development of practice-wide technology solutions. Marc also served as a Managing Director at Grant Thornton LLP, acting as a key international tax resource for the firm’s largest clients and a liaison to its National Tax Office. Throughout his career, Marc has been involved in thousands of M&A transactions across industries (with a keen focus on life sciences, healthcare and technology) and countries, advising on deals ranging from owner-operated businesses to multibillion-dollar corporations. His expertise also includes pioneering tax-efficient supply chain strategies and leading national efforts in valuation-focused international tax services, reflecting his ability to drive innovation and results. Marc’s unparalleled knowledge and experience in complex financial structures and cross-border transactions make him a trusted advisor in healthcare and beyond.

Chief Operating Officer

Mark is a seasoned healthcare executive with extensive experience managing assisted living, memory care, and senior care facilities across multiple states, including NE, KY, FL, OK, and KS. Currently serving as Chief Operating Officer at Emerald Healthcare Management, Mark oversees 16 post-acute, long-term, and assisted living facilities, driving strategic initiatives that enhance clinical and operational outcomes. His leadership has resulted in strong year-over-year EBITDAR growth and consistently high staffing levels. At Nye Healthcare Services, Mark was responsible for the operations and training of seven facilities comprising over 400 beds, fostering a results-oriented and innovative work culture. Earlier, as Executive Director at Golden Living, Mark managed a 181-bed center with short-term, long-term, Alzheimer’s, and assisted living units, achieving patient satisfaction scores of 90–95%. A recipient of multiple honors, including the AHCA Bronze, Silver, and Quality Metrics Awards, Mark’s operational expertise and dedication to excellence make him an invaluable leader in the healthcare industry.

Governance Committee Chief

Scott is a leading antitrust attorney with over 15 years of experience representing healthcare providers, pharmaceutical companies, and technology firms in high-stakes antitrust matters. As Senior Counsel at Hancock Daniel, Scott leads the firm’s antitrust practice, focusing on merger control, joint ventures, government investigations, and litigation. Known for his expertise in “bet the company” antitrust cases, Scott has successfully defended clients in over 40 federal and state investigations and numerous high-profile litigations, including FTC v. Lundbeck Pharma, widely recognized as the “Antitrust Win of the Year.” His strategic, collaborative approach enables clients to anticipate risks, customize deal structures, and maximize transaction value. Scott’s deep understanding of antitrust enforcement and his ability to engage with authorities effectively ensure swift resolutions and minimized disruptions. A frequent contributor to the antitrust bar and author for the ABA, Scott combines regulatory expertise with innovative strategies, making him a trusted advisor in navigating complex antitrust challenges.

Advisor

Douglas is a seasoned corporate and securities attorney with over 23 years as a Partner at Milbank, Tweed, Hadley & McCloy LLP, where he built a distinguished career across global financial markets. He has led diverse corporate and securities practices, including NYSE and NASDAQ SEC-registered IPOs as issuer and underwriter counsel, SEC-registered high-yield and investment-grade debt offerings, Rule 144A debt and equity offerings, private placements, mergers and acquisitions, and corporate governance advisory. Douglas also has significant experience in project financings utilizing private and government funding, tender and exchange offers, private equity investments, and fund organization. During his tenure, he served as Head of the Global Securities Group in New York, Office Founder and Managing Partner of the Silicon Valley Office, and Managing Partner of the Hong Kong Office, where he led the Asia Corporate and Securities Practice. His leadership and expertise have consistently delivered successful outcomes in complex, high-stakes transactions worldwide.

Founding Board Advisor

Michael is universally recognized as thee leading advocate and global expert on Alzheimer's, dementia, and memory loss, with an unparalleled career dedicated to transforming how the world addresses these challenges. A former high-level Fortune 500 manager turned trailblazing advocate, Michael has impacted countless organizations, including the U.S. Government, and inspired dementia-friendly communities worldwide. He is the only U.S. citizen living with Alzheimer’s to have a regular voice at National Alzheimer’s Plan (NAPA) meetings and has spoken at global conferences, such as the World Health Organization’s Global Fight Against Alzheimer’s and Dementia in Geneva. Michael’s advocacy includes influencing AARP policy, having three letters entered into the U.S. Congressional Record, and contributing to the World Alzheimer Report 2012 as the first U.S. citizen featured. He has educated thousands through over 400 media interviews and countless articles, shaping public understanding and professional practices. With memberships and advisory roles across prestigious organizations like UsAgainstAlzheimer’s, the Dementia Action Alliance, and the Milken Institute, Michael’s relentless dedication continues to redefine care, policy, and global awareness for those affected by dementia.